Copyright
©The Author(s) 2020.
World J Clin Cases. Sep 6, 2020; 8(17): 3763-3773
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3763
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3763
Figure 1 Improvement after tocilizumab treatment (computed tomography of the lung shows reduced lung inflammation).
Figure 2 Chest radiography in a patient who subsequently died after tocilizumab treatment (bedside chest radiograph show increased inflammation and significantly increased exudation).
Figure 3 Oxygen therapy and curative effect in 19 patients with Coronavirus Disease 2019.
Figure 4 Trend in each test index between the effective group and ineffective group.
- Citation: Zeng J, Xie MH, Yang J, Chao SW, Xu EL. Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients. World J Clin Cases 2020; 8(17): 3763-3773
- URL: https://www.wjgnet.com/2307-8960/full/v8/i17/3763.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i17.3763